Join to access to all OVN content. Join for Free

Results for 'cancer therapy'

Experiences With CAR T-Cell Therapy
OVN Avatar The Oncology Nursing Podcast
Experiences With CAR T-Cell Therapy

Kathleen Wiley, RN, MSN, AOCNS®, oncology clinical specialist at ONS, sits down with Megan Harvey, MSN, RN, clinical nurse at the Hospital of the University of Pennsylvania, to discuss Harvey's experience with CAR T-cell therapy. Find out more about this immunotherapy treatment in ca…

Oct 24th • 14 mins listen

New Guidelines for Managing Immunotherapy-Related Adverse Events
OVN Avatar The Oncology Nursing Podcast
New Guidelines for Managing Immunotherapy-Related Adverse Events

ONS’s Pamela Ginex, EdD, MPH, RN, OCN®, discusses the new immunotherapy toxicity guidelines released by the National Comprehensive Cancer Network and the American Society of Clinical Oncology. We talk about ONS’s role in helping to develop the information, the importance of educati…

Feb 19th • 13 mins listen

How CAR and Other T Cells Are Revolutionizing Cancer Treatment
OVN Avatar The Oncology Nursing Podcast
How CAR and Other T Cells Are Revolutionizing Cancer Treatment

ONS member Cecily Snyder, BSN, RN, OCN®, BMTCN®, transplant case manager of the blood and marrow transplantation program at Nebraska Medicine in Omaha and member of the Metro Omaha ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss T-cell therapy…

Jan 24th • 27 mins listen

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Highlights From Today’s Episode “With next-generation sequencing (NGS), multiple biomarkers can be evaluated using one test. So, in cancer care, we’re learning that any given tumor may harbor a variety of variants. So, if we’re considering using in situ hybridization (ISH)…

Mar 30th • 47 mins listen

IO Clinical Trials During COVID-19
OVN Avatar Cancer Buzz Podcast
IO Clinical Trials During COVID-19

On this episode of CANCER BUZZ, we look at how immunotherapy clinical trials have been affected by the pandemic and what cancer programs can do to safely and effectively administer clinical trials. Guest: Joanne Riemer, RN, BSN, Research Oncology Nurse, Sidney Kimmel Comprehensive …

Jun 23rd • 13 mins listen

Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility
OVN Avatar Journal of Clinical Oncology (JCO) Podcast
Harnessing the Power of Registries to Understand the Impact of Treatment for Hodgkin Lymphoma on Fertility

Dr. Lindsay Morton of the National Cancer Institute at the National Institutes of Health reflects on research findings by Øvlisen et al that leverage large-scale linked registries in Denmark to suggest that improvements in both chemotherapy treatments and assisted reproductive technologies …

Aug 9th • 10 mins listen

How Biomarker Testing Drives the Use of Targeted Therapies
OVN Avatar The Oncology Nursing Podcast
How Biomarker Testing Drives the Use of Targeted Therapies

ONS member Cyndy Simonson, MS, APRN-BC, AOCN®, oncology nurse practitioner who is the nursing editor at Duke Regional Hospital in Durham, NC, and member of the North Carolina Triangle ONS Chapter, joins Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, to discuss biomarker testi…

Aug 24th • 40 mins listen

Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs
OVN Avatar The Oncology Nursing Podcast
Oncology Pharmacology 2023: Today’s Treatments and Tomorrow’s Breakthroughs

CDER, FDA, Nurses, biomarker, immunomodulatory

Highlights From Today’s Episode “Full approval through the Center for Drug Evaluation and Research (CDER) and FDA means that those drugs have gone through the laboratory testing, human clinical trial testing, and very extensive clinical trials to make sure that they are effective and th…

Mar 30th • 53 mins listen

Related Topics

Loading...